PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Nov-2023 Moberg Pharma´s Interim report January - September 2023 Moberg Pharma
08-Nov-2023 Collaboration agreement with new CT technology partner Kromek Group plc
08-Nov-2023 Shareholders of Abcam Approve Proposed Acquisition by Danaher Abcam plc
08-Nov-2023 Moberg Pharma strengthens the organization Moberg Pharma
08-Nov-2023 Continued strong performance in the third quarter of 2023 SYNLAB AG
08-Nov-2023 Spexis to file an application for a debt-restructuring moratorium Spexis AG
08-Nov-2023 Evotec SE reports results for the first nine months 2023 and provides corporate update Evotec SE
07-Nov-2023 Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA Mainz BioMed N.V.
07-Nov-2023 DEFENCE THERAPEUTICS KEY PLATFORM PATENT ACCEPTED BROADLY COVERING VACCINE TECHNOLOGY Defence Therapeutics Inc.
07-Nov-2023 Evotec and Dewpoint Therapeutics enter strategic partnership in oncology Evotec SE
06-Nov-2023 Lonza Prices CHF 400 Million Dual-Tranche Straight Bonds Lonza Group AG
06-Nov-2023 Krones records strong growth in first three quarters of 2023 and significantly improves profitability Krones
06-Nov-2023 NovalGen announces one oral and one poster presentation at the 65th American Society of Hematology Annual Meeting NovalGen
06-Nov-2023 Cannovum Cannabis AG: Legalization of cannabis is imminent, new premium partners enrich Anbau-Allianz, Cannovum's cultivation alliance Cannovum Cannabis AG
06-Nov-2023 CHEPLAPHARM opens presence in Tokyo Cheplapharm AG
06-Nov-2023 Coriolis Pharma Re-Establishes Chair in Vaccine Development at Leiden University B3C newswire
03-Nov-2023 Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1 Secarna Pharmaceuticals GmbH & Co. KG
03-Nov-2023 MEDICLIN increases Group sales and Group operating result MediClin AG
03-Nov-2023 AEVIS VICTORIA SA – Continued organic growth in the third quarter of 2023 AEVIS VICTORIA SA
02-Nov-2023 SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven SYNLAB AG